Table 2.

Secondary risk estimation due to the equivalent dose estimated for the organs in the out-of-field radiations. Data used from ICRP recommendations.¹⁶

Studied organ	Probability of secondary cancer risk (cases per 10,000 persons)	Fatal risk due to absorbed equivalent dose (cases per 10,000 persons)	Non-Fatal risk due to absorbed equivalent dose (cases per 10,000 persons)	Nominal risk adjusted for lethality and quality of life
1. Thyroid	0.56	0.07	0.08	0.12
2. Esophagus	0.24	0.05	0.07	0.10
3. Lungs	0.93	0.08	0.09	0.16
4. Liver	1.44	0.09	0.09	0.14
5. Stomach	0.89	0.09	0.10	0.17
6. Bone marrow	1.22	0.08	0.08	0.11
7. Small intestine	0.63	0.04	0.05	0.10
8. Large intestine	0.55	0.04	0.04	0.10
9. Bladder	1.93	0.07	0.08	0.99
10. Testes	1.10	0.09	0.09	0.10
11. Skin	51.67	0.13	0.15	0.19
12. Adrenals	0.65	0.07	0.08	0.99
13. Kidney	0.43	0.06	0.07	0.10
14. Pancreas	0.43	0.06	0.07	0.08
15. Spleen	0.38	0.08	0.08	0.98
16. Liver	1.68	0.07	0.07	0.08
17. Leg bone	0.31	0.03	0.05	0.07
18. Spine bones	0.29	0.03	0.05	0.07
19. Scull bone	0.25	0.02	0.04	0.08
20. Brain	0.28	0.01	0.03	0.08
21. Thymus	0.69	0.04	0.05	0.07
22. Uterus	1.66	0.08	0.12	0.18
23. Ovaries	2.29	0.10	0.17	0.23
24. Scapulae	0.51	0.03	0.05	0.08
25. Arm bones	0.99	0.02	0.03	0.06